Update on screening and clinical diagnosis of meticillin-resistant Staphylococcus aureus (MRSA)

Research output: Contribution to journalArticle

Standard

Update on screening and clinical diagnosis of meticillin-resistant Staphylococcus aureus (MRSA). / Harbarth, S; Hawkey, Peter; Tenover, F; Stefani, S; Pantosti, A; Struelens, MJ.

In: International Journal of Antimicrobial Agents, Vol. 37, No. 2, 01.02.2011, p. 110-117.

Research output: Contribution to journalArticle

Harvard

APA

Vancouver

Author

Harbarth, S ; Hawkey, Peter ; Tenover, F ; Stefani, S ; Pantosti, A ; Struelens, MJ. / Update on screening and clinical diagnosis of meticillin-resistant Staphylococcus aureus (MRSA). In: International Journal of Antimicrobial Agents. 2011 ; Vol. 37, No. 2. pp. 110-117.

Bibtex

@article{4e49c5056f024dbab37293fd63d84519,
title = "Update on screening and clinical diagnosis of meticillin-resistant Staphylococcus aureus (MRSA)",
abstract = "Based on the failure of conventional control strategies, some experts and public health officials have promoted active screening to detect asymptomatic carriers of meticillin-resistant Staphylococcus aureus (MRSA) as an effective prevention strategy. Data regarding the (cost-) effectiveness of MRSA screening have recently grown and have produced mixed results. Several clinical studies have not only provided conflicting findings but have also raised numerous issues about the appropriate populations for universal versus targeted screening, screening method(s) and intervention(s). It must also be emphasised that screening alone is not effective. Results should be followed by appropriate interventions to reduce the risk of MRSA transmission and infection. We believe a reasonable approach in most European hospitals with an MRSA on-admission prevalence of ",
keywords = "Prevention, Carriage, MRSA, Economics, Diagnostics, Clinical studies, Infection",
author = "S Harbarth and Peter Hawkey and F Tenover and S Stefani and A Pantosti and MJ Struelens",
year = "2011",
month = feb,
day = "1",
doi = "10.1016/j.ijantimicag.2010.10.022",
language = "English",
volume = "37",
pages = "110--117",
journal = "International Journal of Antimicrobial Agents",
issn = "0924-8579",
publisher = "Elsevier",
number = "2",

}

RIS

TY - JOUR

T1 - Update on screening and clinical diagnosis of meticillin-resistant Staphylococcus aureus (MRSA)

AU - Harbarth, S

AU - Hawkey, Peter

AU - Tenover, F

AU - Stefani, S

AU - Pantosti, A

AU - Struelens, MJ

PY - 2011/2/1

Y1 - 2011/2/1

N2 - Based on the failure of conventional control strategies, some experts and public health officials have promoted active screening to detect asymptomatic carriers of meticillin-resistant Staphylococcus aureus (MRSA) as an effective prevention strategy. Data regarding the (cost-) effectiveness of MRSA screening have recently grown and have produced mixed results. Several clinical studies have not only provided conflicting findings but have also raised numerous issues about the appropriate populations for universal versus targeted screening, screening method(s) and intervention(s). It must also be emphasised that screening alone is not effective. Results should be followed by appropriate interventions to reduce the risk of MRSA transmission and infection. We believe a reasonable approach in most European hospitals with an MRSA on-admission prevalence of

AB - Based on the failure of conventional control strategies, some experts and public health officials have promoted active screening to detect asymptomatic carriers of meticillin-resistant Staphylococcus aureus (MRSA) as an effective prevention strategy. Data regarding the (cost-) effectiveness of MRSA screening have recently grown and have produced mixed results. Several clinical studies have not only provided conflicting findings but have also raised numerous issues about the appropriate populations for universal versus targeted screening, screening method(s) and intervention(s). It must also be emphasised that screening alone is not effective. Results should be followed by appropriate interventions to reduce the risk of MRSA transmission and infection. We believe a reasonable approach in most European hospitals with an MRSA on-admission prevalence of

KW - Prevention

KW - Carriage

KW - MRSA

KW - Economics

KW - Diagnostics

KW - Clinical studies

KW - Infection

U2 - 10.1016/j.ijantimicag.2010.10.022

DO - 10.1016/j.ijantimicag.2010.10.022

M3 - Article

VL - 37

SP - 110

EP - 117

JO - International Journal of Antimicrobial Agents

JF - International Journal of Antimicrobial Agents

SN - 0924-8579

IS - 2

ER -